Viewing Study NCT01652469


Ignite Creation Date: 2025-12-24 @ 11:14 PM
Ignite Modification Date: 2025-12-25 @ 8:49 PM
Study NCT ID: NCT01652469
Status: COMPLETED
Last Update Posted: 2022-08-24
First Post: 2012-07-26
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Testing of Drugs Erlotinib and Docetaxel in Lung Cancer Patients Classified Regarding Their Outlook Using VeriStrat®.
Sponsor: ETOP IBCSG Partners Foundation
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2012-08
Start Date Type: None
Primary Completion Date: 2015-12
Primary Completion Date Type: ACTUAL
Completion Date: 2015-12
Completion Date Type: ACTUAL
First Submit Date: 2012-07-26
First Submit QC Date: None
Study First Post Date: 2012-07-30
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2017-12-22
Results First Submit QC Date: None
Results First Post Date: 2019-08-08
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2022-08-23
Last Update Post Date: 2022-08-24
Last Update Post Date Type: ACTUAL